IL162601A0 - Raf/ras binding proteins, their preparation and use - Google Patents

Raf/ras binding proteins, their preparation and use

Info

Publication number
IL162601A0
IL162601A0 IL16260102A IL16260102A IL162601A0 IL 162601 A0 IL162601 A0 IL 162601A0 IL 16260102 A IL16260102 A IL 16260102A IL 16260102 A IL16260102 A IL 16260102A IL 162601 A0 IL162601 A0 IL 162601A0
Authority
IL
Israel
Prior art keywords
raf
preparation
binding proteins
ras
ras binding
Prior art date
Application number
IL16260102A
Other languages
English (en)
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of IL162601A0 publication Critical patent/IL162601A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL16260102A 2001-12-21 2002-12-20 Raf/ras binding proteins, their preparation and use IL162601A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01000788 2001-12-21
PCT/EP2002/014663 WO2003054193A2 (en) 2001-12-21 2002-12-20 Raf/ras binding compounds

Publications (1)

Publication Number Publication Date
IL162601A0 true IL162601A0 (en) 2005-11-20

Family

ID=8176119

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16260102A IL162601A0 (en) 2001-12-21 2002-12-20 Raf/ras binding proteins, their preparation and use

Country Status (9)

Country Link
US (1) US20050164906A1 (xx)
EP (1) EP1465996B1 (xx)
JP (1) JP2005525092A (xx)
AT (1) ATE413453T1 (xx)
AU (1) AU2002358780B2 (xx)
CA (1) CA2469263A1 (xx)
DE (1) DE60229781D1 (xx)
IL (1) IL162601A0 (xx)
WO (1) WO2003054193A2 (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL367102A1 (en) * 2001-05-02 2005-02-21 Purdue Research Foundation Treatment and diagnosis of macrophage mediated disease
EP1622646B1 (en) * 2003-05-06 2012-08-08 Purdue Research Foundation Treatment of lupus targeting the macrophages or the folate receptor
FR2875136B1 (fr) * 2004-09-10 2007-12-14 Assist Publ Hopitaux De Paris Utilisation de la proteine gilz exprimee dans les cellules dendritiques pour moduler la reponse immune specifique d'un antigene
WO2007006041A2 (en) 2005-07-05 2007-01-11 Purdue Research Foundation Imaging and therapeutic method using monocytes
WO2014172639A1 (en) * 2013-04-19 2014-10-23 Ruga Corporation Raf kinase inhibitors
JP7355742B2 (ja) * 2018-01-18 2023-10-03 フレッド ハッチンソン キャンサー センター 細胞活性状態を調節することにより免疫細胞の炎症状態をインビボで変更すること
US11524091B2 (en) * 2018-08-21 2022-12-13 Augusta University Research Institute, Inc. GILZ formulations for wound healing

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0884385A1 (en) * 1997-04-28 1998-12-16 Applied Research Systems Ars Holding N.V. Intracellular modulators of apoptopic cell death pathways
US6867283B2 (en) * 2001-05-16 2005-03-15 Technion Research & Development Foundation Ltd. Peptides capable of binding to MHC molecules, cells presenting such peptides, and pharmaceutical compositions comprising such peptides and/or cells

Also Published As

Publication number Publication date
DE60229781D1 (de) 2008-12-18
ATE413453T1 (de) 2008-11-15
JP2005525092A (ja) 2005-08-25
WO2003054193A2 (en) 2003-07-03
US20050164906A1 (en) 2005-07-28
CA2469263A1 (en) 2003-07-03
EP1465996A2 (en) 2004-10-13
AU2002358780B2 (en) 2008-03-06
WO2003054193A3 (en) 2003-10-23
AU2002358780A1 (en) 2003-07-09
EP1465996B1 (en) 2008-11-05

Similar Documents

Publication Publication Date Title
DE69824029D1 (de) Bicyclische kinase inhibitoren
MXPA03010207A (es) Nuevas 4-anilinoquinolin-3-carboxamidas.
ID27535A (id) Turunan pirasola sebagai inhibitor p-38 map kinase
MXPA02011320A (es) Derivados de pirazol triciclico como inhibidores de cinasa.
HK1087700A1 (en) Triazolopyridazines as protein kinases inhibitors
ATE419253T1 (de) Inhibitoren von thienopyridin- und furopyridinkinase
WO2005009389A3 (en) Anaplastic lymphoma kinase modulators and methods of use
IS2376B (is) Þíenópýrimidíndíón og notkun þeirra í breytingu ásjálfsnæmissjúkdómi
WO2005116025A3 (en) 2-substituted-4-heteroaryl-pyrimidines useful for the treatment of proliferative disorders
ATE435210T1 (de) Tetrahydroisochinolylacetamidderivate zur verwendung als orexinrezeptorantagonisten
MXPA05012026A (es) Compuestos de azaindol como inhibidores de cinasa.
WO2001087882A3 (en) Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
IL179883A0 (en) 4,6-disubstituted pyrimidine derivatives and pharmaceutical compositions containing the same
MXPA05013076A (es) Compuestos de isoindolina-1-ona como inhibidores de cinasa.
WO2004093800A3 (en) Thyronamine derivatives and analogs and methods of use thereof
IL162601A0 (en) Raf/ras binding proteins, their preparation and use
WO2005055943A3 (en) Vinorelbine derivatives
SE9904128D0 (sv) Novel compounds
PL369953A1 (en) Glycosylphosphatidylinositol containing polypeptides
WO2002008227A3 (en) Bicyclic hydantoin derivatives and combinatorial libraries thereof
NO20030801L (no) Aminoalkenylbenzoyl-benzofuran- eller benzotiofenderivater, fremgangsmåte for deres fremstilling og preparater inneholdende de samme
WO2006124813A3 (en) Substituted 7, 8-dihydro-1h-pyrimido [4,5-b] [1,4] diazepin-4-amines as?kinase inhibitors